Literature DB >> 8431905

Conservative management of early vulvar cancer.

N F Hacker1, J Van der Velden.   

Abstract

There is a definite trend toward vulvar conservation and individualized management of patients with early vulvar cancer. This approach initially was used only for patients with T1 disease, but with increasing experience with conservative surgery and the integration of postoperative adjuvant radiation when appropriate, some investigators have broadened the indications to include carefully selected patients with T2 lesions. A recent literature review suggests that the local invasive recurrence rate for T1 disease is 7.2% (12 of 165) after radical local excision compared with 6.3% (23 of 365) after radical vulvectomy (P = 0.85). Surgical margins must be at least 1 cm, and the rest of the vulva must be healthy if an increased local recurrence rate is to be avoided. Local recurrences usually can be treated successfully if diagnosed early, but recurrence in the groin is usually fatal. Inguinal-femoral lymphadenectomy should be done on all patients if the primary tumor is more than 2 cm in diameter and in patients with T1 disease in whom the depth of invasion is greater than 1 mm. Separate groin incisions may be used, but pelvic and groin irradiation should be given if there is at least one large node replaced with tumor or multiple nodes containing micrometastases. Careful patient selection is critical if modified operations are used, or an increased rate of recurrence will follow.

Entities:  

Mesh:

Year:  1993        PMID: 8431905     DOI: 10.1002/cncr.2820710436

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  15 in total

1.  Surviving gynecologic cancer and coping with sexual morbidity: an international problem.

Authors:  B.L. Andersen; J. van Der Does
Journal:  Int J Gynecol Cancer       Date:  1994-07       Impact factor: 3.437

2.  Groin lymphadenectomy with preservation of femoral fascia: total inguinofemoral node dissection for treatment of vulvar carcinoma.

Authors:  Leonardo Micheletti; Fabrizio Bogliatto; Marco Massobrio
Journal:  World J Surg       Date:  2005-10       Impact factor: 3.352

3.  Management options for vulvar carcinoma in a low resource setting.

Authors:  Ahizechukwu C Eke; Lilian I Alabi-Isama; Josephat C Akabuike
Journal:  World J Surg Oncol       Date:  2010-11-01       Impact factor: 2.754

Review 4.  Management of lymph nodes in the treatment of vulvar cancer.

Authors:  Toshiaki Saito; Keiji Kato
Journal:  Int J Clin Oncol       Date:  2007-06-27       Impact factor: 3.402

Review 5.  Primary groin irradiation versus primary groin surgery for early vulvar cancer.

Authors:  Jacobus van der Velden; Guus Fons; Theresa A Lawrie
Journal:  Cochrane Database Syst Rev       Date:  2011-05-11

6.  An alternative way to measure the depth of invasion of vulvar squamous cell carcinoma in relation to prognosis.

Authors:  Loes C G van den Einden; Leon F A G Massuger; Johanna K Jonkman; Peter Bult; Joanne A de Hullu; Johan Bulten
Journal:  Mod Pathol       Date:  2014-09-05       Impact factor: 7.842

7.  Validation and application of the sentinel lymph node concept in malignant vulvar tumours.

Authors:  Sergi Vidal-Sicart; Lluís María Puig-Tintoré; José Antonio Lejárcegui; Pilar Paredes; María Luisa Ortega; Antonio Muñoz; Jaume Ordi; Pere Fusté; Jaime Ortín; Joan Duch; Francisco Martín; Francesca Pons
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-09-28       Impact factor: 9.236

Review 8.  Vulvar carcinoma.

Authors:  R L Coleman; J T Santoso
Journal:  Curr Treat Options Oncol       Date:  2000-06

9.  Pregnancy following vulvar squamous cell carcinoma: a report of two cases.

Authors:  Julia E Palmer; John A Tidy
Journal:  J Gynecol Oncol       Date:  2009-12-28       Impact factor: 4.401

Review 10.  Chemotherapy of vulvar cancer: a review.

Authors:  Gunter Deppe; Ismail Mert; Jimmy Belotte; Ira S Winer
Journal:  Wien Klin Wochenschr       Date:  2013-03-22       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.